These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12125906)

  • 1. A case of impairment of mitochondrial fatty acid beta-oxidation.
    Hasegawa T; Hori N; Du W
    Keio J Med; 2002 Jun; 51(2):100-6. PubMed ID: 12125906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of mitochondrial fatty acid oxidation defects.
    Duran M; Bruinvis L; Ketting D; Dorland L
    Padiatr Padol; 1993; 28(1):19-25. PubMed ID: 8446424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dietary fatty acid chain-length on metabolic tolerance in mouse models of inherited defects in mitochondrial fatty acid beta-oxidation.
    Schuler AM; Gower BA; Matern D; Rinaldo P; Wood PA
    Mol Genet Metab; 2004 Dec; 83(4):322-9. PubMed ID: 15589119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels.
    Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L
    Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
    Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
    Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of mitochondrial fatty acid oxidation defects.
    Nada MA; Vianey-Saban C; Roe CR; Ding JH; Mathieu M; Wappner RS; Bialer MG; McGlynn JA; Mandon G
    Prenat Diagn; 1996 Feb; 16(2):117-24. PubMed ID: 8650121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases.
    Wasant P; Matsumoto I; Naylor E; Liammongkolkul S
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S710-9. PubMed ID: 12403251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation.
    Schuler AM; Gower BA; Matern D; Rinaldo P; Vockley J; Wood PA
    Mol Genet Metab; 2005 May; 85(1):7-11. PubMed ID: 15862275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Very-long-chain acyl-CoA dehydrogenase deficiency presenting with recurrent rhabdomyolysis in an adult].
    Hamano H; Shinohara Y; Takizawa S; Tokuoka K; Kazahari S; Mandokoro H; Sato A
    Rinsho Shinkeigaku; 2003 May; 43(5):253-7. PubMed ID: 12931630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
    Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
    Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase.
    Clark-Taylor T; Clark-Taylor BE
    Med Hypotheses; 2004; 62(6):970-5. PubMed ID: 15142659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients.
    Aoyama T; Souri M; Ushikubo S; Kamijo T; Yamaguchi S; Kelley RI; Rhead WJ; Uetake K; Tanaka K; Hashimoto T
    J Clin Invest; 1995 Jun; 95(6):2465-73. PubMed ID: 7769092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.
    Aoyama T; Uchida Y; Kelley RI; Marble M; Hofman K; Tonsgard JH; Rhead WJ; Hashimoto T
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1369-72. PubMed ID: 8466512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies.
    Nouws J; Te Brinke H; Nijtmans LG; Houten SM
    Hum Mol Genet; 2014 Mar; 23(5):1311-9. PubMed ID: 24158852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Generalized epilepsy disclosing medium-chain-acyl-CoA dehydrogenase deficiency].
    Chabrol B; Mancini J; Bertrand C; Vianey-Saban C; Divry P; Livet MO; Pinsard N
    Arch Fr Pediatr; 1993; 50(6):497-500. PubMed ID: 8135611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood.
    Rocchiccioli F; Wanders RJ; Aubourg P; Vianey-Liaud C; Ijlst L; Fabre M; Cartier N; Bougneres PF
    Pediatr Res; 1990 Dec; 28(6):657-62. PubMed ID: 2284166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.